Diabetes Kongress 2019
Kalender Liste Personen Favoriten
zur Liste
Prof. Dr. med. Stefan D. Anker
Charité – Universitätsmedizin Berlin Germany
  • Vortrag Design and rationale of the EMPEROR trials of, empagliflozin 10 mg once daily, in patients with chronic heart failure with reduced ejection fraction (EMPEROR-Reduced) or preserved ejection fraction (EMPEROR-Preserved) Speaker
    Datum: 31.05.2019 , Zeit: 11:30 | Thema: 03. Grundlagenforschung Typ-1-Diabetes/ Betazelle/ Typ-1-Diabetes/ Adipositas/ Fettgewebe
    Details
  • Vortrag Design of the Effect of EMPaglifozin on ExeRcise ability and HF-symptoms, In patients with chronic heArt faiLure (EMPERIAL) trials of empagliflozin in patients with chronic heart failure with reduced or preserved ejection fraction Autor:in
    Datum: 31.05.2019 , Zeit: 11:40 | Thema: 03. Grundlagenforschung Typ-1-Diabetes/ Betazelle/ Typ-1-Diabetes/ Adipositas/ Fettgewebe
    Details